Maternal obesity and risk for birth defects

Margaret L Watkins1, Sonja A Rasmussen, Margaret A Honein

  • 1Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. mwatkins@cdc.gov

Pediatrics
|May 3, 2003
PubMed

Insights

Maternal obesity before pregnancy increases the risk of birth defects like spina bifida and heart defects. Maintaining a healthy weight before conception is crucial for preventing adverse pregnancy outcomes.

Area of Science:

  • Reproductive Health
  • Pediatric Health
  • Public Health

Background:

  • Maternal obesity is a growing concern in reproductive health.
  • Previous research indicates a link between prepregnancy obesity and neural tube defects.
  • Limited recent data exists on the association between maternal prepregnancy weight status and a broader range of birth defects.

Purpose of the Study:

  • To investigate the relationship between maternal prepregnancy obesity and overweight with various birth defects.
  • To compare current findings with existing literature on maternal weight and birth defect risks.

Main Methods:

  • A population-based case-control study was conducted using data from the Atlanta Birth Defects Risk Factor Surveillance Study.
  • Mothers of infants with and without selected birth defects were interviewed.
  • Maternal body mass index (BMI) was calculated, excluding women with pre-existing diabetes. Risks were compared between obese (BMI ≥30), overweight (BMI 25.0-29.9), and average-weight (BMI 18.5-24.9) women.

Main Results:

  • Obese women showed increased odds for infants with spina bifida, omphalocele, heart defects, and multiple anomalies.
  • Overweight women had increased odds for infants with heart defects and multiple anomalies compared to average-weight women.
  • Specific odds ratios and confidence intervals were reported for each association.

Conclusions:

  • The study confirms the association between prepregnancy maternal obesity and spina bifida.
  • New associations were identified between maternal obesity and omphalocele, heart defects, and multiple anomalies.
  • Prepregnancy overweight was linked to heart defects and multiple anomalies, highlighting the need for obesity prevention in women of childbearing age.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...